Antimitotic Agents: all 5,052 studies that test it
Page 31 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.
- Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast CancerWithdrawnNCT02102438Not applicable
- A Clinical Trial on Efficacy and Safety for Lobaplatin and Gemcitabine in Combination With Docetaxel in the Second-line Treatments on Advanced OsteosarcomaStatus unknownNCT02099396Phase 2/3
- Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable PatientsStatus unknownNCT02099188Phase 2
- Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable PatientsStatus unknownNCT02099175Phase 2
- COlchicine Improve EnDothElial Function in Non ST Elevation Myocardial Infarction PatientsWithdrawnNCT02095522Not applicable
- Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian CancerCompletedNCT02092363Phase 1
- LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian CarcinomaWithdrawnNCT02083536Phase 1
- Apolipoprotein CIII Reduction Via ColchicineCompletedNCT02083510Early Phase 1
- Study of Eribulin in Children With Cancer to Determine SafetyTerminatedNCT02082626Phase 1
- Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric CancerTerminatedNCT02076594Phase 3
- The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC）Status unknownNCT02076477Phase 3
- T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast CancerCompletedNCT02073916Phase 1
- Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic LeukemiaStatus unknownNCT02072785Phase 3
- Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid TumorCompletedNCT02069158Phase 1
- PREDATOR: Neoadjuvant Gene Prediction for Breast CancerWithdrawnNCT02067416Phase 2
- Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction PatientsCompletedNCT02066103Not applicable
- Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain MetastasesWithdrawnNCT02065466Phase 1/2
- Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast CancerCompletedNCT02064829Not applicable
- Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast CancerCompletedNCT02060253Phase 1
- Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLCWithdrawnNCT02059967Phase 1
- Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast CancerStatus unknownNCT02059876Phase 2
- A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP)CompletedNCT02057913Phase 2
- A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib TrialCompletedNCT02057380Phase 2
- SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHNCompletedNCT02057107Phase 2
- PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian CancerTerminatedNCT02055690Phase 1/2
- F16IL2 Plus Paclitaxel in Metastatic Merkel Cell CarcinomaTerminatedNCT02054884Phase 2
- TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free RegimenWithdrawnNCT02053597Phase 2
- International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly PaclitaxelStatus unknownNCT02051868Phase 2
- A Study to Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck CancerCompletedNCT02051751Phase 1
- Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic CancerCompletedNCT02050178Phase 1
- Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerWithdrawnNCT02050009Phase 1
- A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)TerminatedNCT02049281Phase 1
- Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic CancerWithdrawnNCT02048943Phase 1
- ANG1005 in Breast Cancer Patients With Recurrent Brain MetastasesCompletedNCT02048059Phase 2
- Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx CancerCompletedNCT02048020Phase 2
- Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin TherapyTerminatedNCT02047214Phase 2
- Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCCCompletedNCT02047201Phase 2
- Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid TumorsCompletedNCT02045602Phase 1
- A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic CancerCompletedNCT02045589Phase 1
- Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate CancerCompletedNCT02044354Phase 3
- Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer.CompletedNCT02043730Phase 2
- Biweekly Docetaxel in Patients With Metastatic Breast Cancer.CompletedNCT02041351Phase 2
- Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast CancerStatus unknownNCT02041338Phase 2
- Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid TumorsTerminatedNCT02040558Phase 1
- The Maintenance Therapy of Capecitabine of Advanced Gastric CancerStatus unknownNCT02038621Phase 2
- FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal AdenocarcinomaActive, not recruitingNCT02037048Phase 2
- Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic LeukemiaCompletedNCT02036489Phase 4
- Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of stageIIIA Lung caStatus unknownNCT02036359Phase 2
- Adjuvant Chemotherapy for Locally Advanced Cervical CancerStatus unknownNCT02036164Phase 3
- Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer.CompletedNCT02036060Phase 2
- Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and MicroalbuminuriaStatus unknownNCT02035891Not applicable
- DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).CompletedNCT02035813Phase 2
- Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT02035527Phase 1
- Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With DocetaxelWithdrawnNCT02035124Phase 2
- Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of EsophagusWithdrawnNCT02033538Phase 2
- Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung CancerStatus unknownNCT02031601Phase 4
- A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian CancerCompletedNCT02026921Phase 2
- Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative ResectionCompletedNCT02023021Phase 2
- Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersCompletedNCT02020707Phase 1
- Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung CancerStatus unknownNCT02016209Phase 2
- Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid TumorsCompletedNCT02014337Phase 1
- A Study of DKN-01 in Combination With Paclitaxel or PembrolizumabCompletedNCT02013154Phase 1
- MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric CancerStatus unknownNCT02007148Phase 2
- A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic CancerCompletedNCT02005315Phase 1
- Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric CancerCompletedNCT02004769Phase 2
- Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠBStatus unknownNCT02001168Phase 3
- Evaluation of Postoperative Radiotherapy and Concurrent Chemotherapy Effectiveness in Cervical CancerStatus unknownNCT01999933Phase 2/3
- Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal CancerWithdrawnNCT01998347Phase 3
- Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional TreatmentsStatus unknownNCT01994031Phase 4
- AMG 386 Drug-Drug Interaction Study With PaclitaxelCompletedNCT01992341Phase 1
- An Efficacy Study Of Ortataxel In Recurrent GlioblastomaCompletedNCT01989884Phase 2
- Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast CancerTerminatedNCT01985841Phase 2
- The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen DeprivationWithdrawnNCT01981668Phase 1
- First Line Chemotherapy for Advanced CancerTerminatedNCT01980810Phase 2
- Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer PatientsStatus unknownNCT01980472Phase 2
- Phase Ib/II Study of LY2780301 in Combination With Weekly PACLITAXEL in HER2-metastatic Breast CancerTerminatedNCT01980277Phase 1/2
- Efficacy Study Evaluating Chemotherapy in Prostate CancerStatus unknownNCT01978873Phase 3
- Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)Status unknownNCT01971281Phase 1/2
- Treatment of Patients With Advanced Pancreatic Cancer After Gemcitabine Failure.CompletedNCT01971034Phase 2
- Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal CancerActive, not recruitingNCT01970722Phase 1
- Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung CancerStatus unknownNCT01969955Phase 2
- Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast CancerCompletedNCT01969032Phase 2
- A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric CancerTerminatedNCT01967875Phase 2
- A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced MalignanciesCompletedNCT01967043Phase 1
- A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TPI-287 in Alzheimer's DiseaseCompletedNCT01966666Phase 1
- A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGCStatus unknownNCT01963702Phase 2
- S-1 in Combination With Abraxane in Treating CholangiocarcinomaCompletedNCT01963325Phase 2
- Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid TumorsCompletedNCT01957995Phase 1
- A Study of Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLCCompletedNCT01957007Phase 1
- Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric CancerCompletedNCT01956149Phase 2
- LDE225 and Paclitaxel in Solid TumorsCompletedNCT01954355Phase 1
- Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)WithdrawnNCT01953536Phase 2
- Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast CancerWithdrawnNCT01953445Phase 2
- A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of RelapseActive, not recruitingNCT01952223Phase 3
- Docetaxel and Lycopene in Metastatic Prostate CancerCompletedNCT01949519Phase 1
- First Line Metastatic Breast Cancer Treatment (ESMERALDA)CompletedNCT01941407Phase 2
- Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung CancerWithdrawnNCT01938456Phase 1
- Colchicine in ST-elevation Myocardial InfarctionStatus unknownNCT01936285Phase 4
- 8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast CancerCompletedNCT01935492Phase 3
- Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic CancerStatus unknownNCT01934634Phase 1